Partner Content Partner Content New Dates Released for J+D's Pharma Forecasting Training J+D releases new forecasting training dates
Events Partner Content J+D Forecasting bring their Face-to-Face Pharma training to ... Face-to-Face Pharma Forecasting Training in Boston
Events Partner Content J+D Forecasting bring their Oncology Forecasting Training to... Oncology Forecasting Training In Boston by J+D Forecast
Events Partner Content Limited Places Available for J+D Forecasting Training Zurich Limited places for J+D's Pharma Forecasting Training
Partner Content Partner Content J+D and the University of Bath School of Management Collabor... J+D recently provided forecasting training materials to the Strategy & Organisation Division of the University of Bath School of Management.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.